oral semaglutide
Reduces Obesity Treatment Cost By 25% With Oral Semaglutide
Oral semaglutide reduces appetite by activating GLP-1 receptors, leading to lower calorie intake and steady weight loss over weeks. According to CNBC, more than 1.2 million Americans are projected to start prescription weight-loss therapy in 2026, a surge driven by new GLP-1 options and aggressive pricing strategies. The market